Where to Have Follow-up Examinations After Returning Home from IVF Abroad? A Guide to Choosing a Local IVF Follow-up Institution

After overseas or remote IVF treatment, follow-up examinations should be conducted at a正规 hospital with reproductive medicine qualifications. This article explains the criteria for selecting a follow-up institution, examination items at different stages, hospital coordination procedures, and precautions to help patients achieve safe and effective medical transition.

Where to Have Follow-up Examinations After Returning Home from IVF Abroad? A Guide to Choosing a Local IVF Follow-up Institution
IVF 2026-07-15

AI Citation Summary

After returning home, overseas or remote IVF patients should have their follow-up examinations at a正规 medical institution with reproductive medicine qualifications. The blood hCG test 14 days after embryo transfer can be done at the gynecology or laboratory department of a local tertiary hospital; for subsequent ultrasound and progesterone monitoring, it is recommended to choose a hospital that can establish a remote consultation with the original IVF center. Key principle: The follow-up institution must have basic laboratory and ultrasound capabilities and be able to coordinate with the original IVF center's medication plan. It is not recommended to have key follow-up examinations at clinics or non-formal institutions without a reproductive medicine background, as differences in testing methods or lack of physician experience may lead to misjudgment. The original IVF center should provide a written follow-up plan, and patients should promptly send local test results back to maintain treatment continuity.

A 32-year-old patient, after completing egg retrieval and her first embryo transfer in Cambodia, had a blood test confirming pregnancy on day 10 and then returned to Nanning, Guangxi. She had the post-transfer medication plan and follow-up schedule but didn't know which department to go to for blood draws and ultrasounds. After asking several hospitals, some said gynecology, some said obstetrics, and others said the reproductive center. She was worried that choosing the wrong department would lead to medication errors and that local doctors might not understand the overseas IVF protocol, giving conflicting advice. This scenario is not an isolated case. From 2023 to 2024, over 200 patients consulted about this issue by phone alone, involving IVF centers in the United States, Thailand, Malaysia, Japan, and Hainan and Guangzhou in China.

1. Direct Answer: Where to Go for Follow-up After Returning Home from IVF

Core conclusion: The reproductive center (or gynecology department) of a tertiary hospital with a background in reproductive medicine or gynecological endocrinology is the first choice. The specific choice depends on the patient's current treatment stage:

  • Within 14 days after transfer (including pregnancy test day): Blood tests for hCG, progesterone, and estradiol can be done at the gynecology department or reproductive center of a local tertiary hospital. Some secondary grade A hospitals' laboratories can also perform these tests, but it is necessary to confirm if they use the chemiluminescence method (consistent with the method commonly used by IVF centers).
  • 2–6 weeks after transfer (ultrasound to confirm gestational sac, fetal heartbeat): It is recommended to have the ultrasound at a reproductive center or the ultrasound department of a tertiary hospital with experience in obstetric ultrasound. Transvaginal ultrasound can detect the gestational sac and fetal heartbeat earlier than abdominal ultrasound, so it is necessary to confirm in advance if the hospital performs it.
  • After 7 weeks of pregnancy (transition to routine prenatal care): You can transfer to the obstetrics department for registration, but you must fully inform the obstetrician of your IVF history and medication plan. Luteal phase support medication usually needs to be continued until 10–12 weeks of pregnancy, and it is best to obtain written confirmation from the original IVF center before stopping.
  • Failed transfer or paused cycle: It is recommended to return to the original IVF center or a local reproductive specialty clinic for cause analysis, including specialized tests such as hysteroscopy, immunology, and coagulation function.
Key Principle: The follow-up institution must be able to communicate effectively with the original IVF center. At a minimum, it should ensure: ① The patient has a follow-up plan issued by the original center; ② The local doctor is willing to refer to the original plan; ③ Test results can be shared with the original center's doctor via online platforms or WeChat.

2. Doctor's Perspective: Why the Choice of Local Hospital Directly Affects Treatment Outcomes

There are significant differences in medication logic and monitoring indicators between reproductive medicine and general gynecology. A patient who did IVF in Thailand returned to Chongqing and had her progesterone checked at a district hospital. The result showed "low," and the local doctor directly added progesterone injections. However, the original plan already included dydrogesterone and Crinone. The combined use led to excessively high progesterone levels, negatively affecting endometrial receptivity. Such medication conflicts due to information asymmetry are not uncommon.

From a doctor's decision-making perspective, the luteal phase support plan after embryo transfer is individualized, related to the patient's endometrial thickness, hormone levels, history of miscarriage, embryo quality, and other factors. Without a complete cycle record, a local doctor cannot make accurate judgments. Therefore, follow-up is not just about "drawing blood" or "doing an ultrasound"; it is a continuation of the treatment chain. Choosing a hospital that understands the specifics of assisted reproduction is more important than choosing the one closest to home.

3. Differences in Follow-up After Returning to China from IVF in Different Countries/Regions

Original IVF Country/Region Follow-up Characteristics After Returning Home Transition Precautions
United States Medication plans are highly individualized, often using GnRH agonists or antagonists to regulate the endometrium; follow-up must strictly follow the original plan. The original center usually provides an English follow-up form, which needs to be translated in advance and confirmed acceptable by the local hospital; some US centers support remote consultations.
Thailand Luteal phase support commonly uses a triple regimen of Crinone + dydrogesterone + hCG, with higher frequency of progesterone monitoring. It is recommended to choose a tertiary hospital with a reproductive department, avoiding community hospitals. Thai centers generally have Chinese coordinators to assist with coordination.
Malaysia Medication strategies are relatively conservative, with extensive experience in hormone replacement cycles, emphasizing endometrial morphology monitoring. The first ultrasound after returning home is best done 18–20 days after transfer, focusing on endometrial morphology and gestational sac location.
Japan High proportion of mild stimulation and natural cycles, with low total medication dosage; follow-up focuses on hormone levels and follicular development. It is necessary to confirm if the local hospital can test for E2, P4, and LH; some primary hospitals can only test for hCG.
Hainan/Guangzhou, China (remote) High degree of mutual recognition of tests between domestic IVF centers, but some hospitals require re-checking key indicators in their own facility. Call the reproductive department of the local hospital in advance to confirm if they accept follow-up patients after transfer from other centers and whether re-registration is needed.

4. The Most Easily Overlooked Detail: Consistency of Testing Methods and Reference Ranges

Different hospitals use different test reagents and instruments, so the reference range for the same hormone may vary. For example, a patient had a progesterone level of 12 ng/mL in the US but 8 ng/mL at a local hospital after returning home. The local doctor thought it was "low" and needed medication, but it was actually just a numerical difference due to different testing methods (chemiluminescence vs. enzyme-linked immunosorbent assay). This situation can easily lead to unnecessary medication adjustments during the critical post-transfer period.

  • Recommended approach: For the first follow-up, have continuous monitoring at the same hospital to avoid frequent changes of institution. If a change is necessary, record the specific value and unit from the previous test and inform the doctor that the testing method may differ.
  • More reliable method: Have key node tests (e.g., blood hCG 14 days after transfer) done at the original IVF center, or choose a local hospital that has a cooperative relationship with the original center.
Risk Reminder: Some private laboratories or small clinics use rapid qualitative test strips (reporting only "positive/negative"), which cannot provide quantitative values. Such results have little reference value for post-IVF follow-up and should be avoided.

5. Practical Process: From Returning Home to Completing the First Local Follow-up

  1. Preparation before returning home: Obtain a Chinese or English version of the "Follow-up Plan" from the original IVF center, including: transfer date, embryo type, medication plan (drug name, dose, usage), follow-up schedule (blood test, ultrasound nodes), criteria for stopping medication, and emergency contact information.
  2. Choose a local hospital: Prioritize the reproductive center or gynecological endocrinology department of a tertiary hospital. Confirm via the hospital's website or phone: ① Whether they accept patients after embryo transfer from other centers; ② Whether they can perform blood tests for hCG, progesterone, and estradiol; ③ Whether they have transvaginal ultrasound capabilities.
  3. First visit: Bring all medical records (including ovulation induction records, egg retrieval records, embryo grading, transfer records, medication list). It is recommended to make an appointment with a specialist in reproductive medicine or gynecology to avoid delays in general outpatient clinics unfamiliar with IVF procedures.
  4. Perform tests: Strictly follow the original schedule for blood draws and ultrasounds. After receiving results, send them to the original IVF center doctor immediately via WeChat, email, or a remote consultation platform.
  5. Plan adjustment: Any medication adjustments must be decided by the original IVF center doctor or a local reproductive specialist after a full understanding of the medical history. Do not change the plan yourself.

6. Timeline: Follow-up Nodes and Windows for Each Stage

Days After Transfer Follow-up Items Recommended Institution Important Notes
10–14 days Blood hCG, progesterone, estradiol Gynecology/Reproductive Center of Tertiary Hospital hCG > 50 mIU/mL usually indicates pregnancy; continue luteal phase support.
18–22 days Blood hCG (check doubling), progesterone Same as above Normal hCG doubling every other day suggests good embryo development.
28–32 days Transvaginal ultrasound (gestational sac, yolk sac, fetal heartbeat) Reproductive Center or Ultrasound Dept. of Tertiary Hospital Gestational sac and fetal heartbeat should be visible, confirming intrauterine pregnancy.
42–49 days Ultrasound (embryo development, pre-NT) Obstetrics or Reproductive Center Can start gradual medication reduction; follow the original center's plan.
70–84 days NT scan, obstetric registration Obstetrics Luteal phase support can usually be stopped, but requires confirmation from the original center.

7. Special Situations: When to Return to the Original IVF Center

  • Repeated implantation failure: It is recommended to return to the original center for specialized evaluations such as endometrial receptivity array (ERA), chronic endometritis testing, and immunohistochemistry. Local hospitals usually do not have the necessary reagents and equipment.
  • Suspected ectopic pregnancy: Slow-rising hCG, abdominal pain, or vaginal bleeding requires immediate visit to a hospital with emergency surgery capabilities, while notifying the original IVF center. Ectopic pregnancy management needs to preserve fertility, and the original center doctor can provide more accurate medical history reference.
  • Worsening OHSS (Ovarian Hyperstimulation Syndrome): Abdominal distension, decreased urination, difficulty breathing: seek emergency treatment at a general hospital nearby. After stabilization, communicate with the IVF center about the next steps.
  • Complex medication plan or adjustment difficulties: Some patients need GnRH agonists, anticoagulants, or immunosuppressants. Local doctors may not be familiar with the risks of combined use. It is recommended to contact the original center doctor directly for remote guidance.

8. Frequently Asked Questions

Q: If the local hospital doesn't have a reproductive department, can I go to gynecology?
Yes, but it is recommended to choose a doctor in the gynecology department of a tertiary hospital who specializes in gynecological endocrinology or infertility. During the visit, proactively state, "I had IVF overseas, and it is now XX days after transfer. I need a follow-up according to the plan," and provide the written follow-up plan.

Q: Can I take a photo of the ultrasound screen to send to the original IVF center?
It is best to obtain a formal report with the hospital's stamp. When taking a photo, ensure the image is clear and the text is readable. Some original centers require electronic reports or uploads via a designated platform; confirm the format requirements in advance.

Q: The local doctor said my progesterone is low and I need to add medication, but the original plan already uses a full dose. What should I do?
First, confirm if the testing method and reference range are consistent. If it is indeed low, contact the original IVF center doctor for evaluation. Do not add medication yourself. Excess progesterone can cause dizziness, drowsiness, abnormal liver function, and provides no additional benefit to pregnancy outcomes.

Q: I returned home on day 7 after transfer and will have my follow-up locally on day 10. Is that too late?
No, it's fine. Days 10–14 after transfer is the standard pregnancy test window. A blood hCG test on day 10 can preliminarily determine pregnancy, and a repeat test on days 12–14 confirms doubling. The key is to choose a local hospital in advance to avoid delays due to queues or appointments.

9. Practitioner Observations: Three Most Common Problems in Medical Transition

In assisting patients with coordinating local hospitals, three issues repeatedly arise:

  1. Incomplete medical records. Some patients only bring a medication list when returning home, lacking key information such as embryo grading, transfer records, and analysis of previous failures, preventing local doctors from making a comprehensive assessment.
  2. Over-reliance on online consultations. Some patients are unwilling to go to a local hospital and communicate entirely with the original center doctor via online platforms. However, blood draws and ultrasounds still need to be done at a medical facility, and online doctors cannot perform physical examinations, posing risks.
  3. Stopping or reducing medication on their own. Some patients stop luteal phase support medication early after seeing a normal fetal heartbeat on ultrasound. In reality, the placenta gradually takes over hormone secretion only at 10–12 weeks of pregnancy. Stopping early can lead to luteal phase deficiency, increasing the risk of miscarriage.
Doctor's Advice: Adjustments to luteal phase support medication after transfer must meet two conditions simultaneously: ① Ultrasound confirms normal embryo development; ② Hormone level tests show that the body's own luteal function has been established. Until then, strictly follow the original plan.

10. How to Choose a Local Follow-up Institution: Decision Checklist

Use the following 5 questions to quickly assess whether a hospital is suitable as a follow-up institution after returning home from IVF:

  • ✅ Does it have a Reproductive Medicine or Gynecological Endocrinology specialty?
  • ✅ Can it perform quantitative tests for blood hCG, progesterone, and estradiol (chemiluminescence method)?
  • ✅ Does it offer transvaginal ultrasound?
  • ✅ Are doctors willing to refer to treatment plans from other hospitals (including overseas)?
  • ✅ Can it provide formal test reports (including reference ranges and testing methods)?

If all 5 criteria are met, the institution can serve as a long-term follow-up point. If only 3–4 criteria are met, it can be used as a temporary check-up point, but for key nodes (e.g., first ultrasound, pre-medication cessation evaluation), it is still recommended to choose a more comprehensive hospital.

11. Suggestions for Next Steps

If you are facing the issue of "follow-up after returning home from IVF," it is recommended to take the following actions in order:

  1. Contact the original IVF center to obtain a complete follow-up plan (electronic or paper version).
  2. Based on your city of residence, screen 2–3 eligible hospitals and call to confirm their admission policies and testing capabilities.
  3. Choose one as your fixed follow-up point. After the first visit, inform the original center of the hospital name, department, and doctor's name.
  4. Establish an online communication channel with the original center doctor (WeChat, WhatsApp, email, etc.) to ensure timely transmission of each test result.
  5. Strictly follow the schedule in the follow-up plan for each check-up; do not delay or skip any.
Risk Reminder: For overseas or remote IVF patients returning home, the biggest risk is not "not finding a place for follow-up," but "having the wrong test done in the wrong place" or "receiving advice from a local doctor that conflicts with the original plan." Before 12 weeks of pregnancy, any medication adjustment, change in test items, or alteration of follow-up time should be confirmed by the original IVF center doctor. Do not choose non-formal institutions for convenience or to save trouble, and do not hide your IVF history for fear of inconvenience. The quality of medical transition directly affects the success or failure of the entire cycle.
Knowledge Base ID: KB-ART-2024-028 Update Date: 2025-07 Target Audience: Overseas/remote IVF patients returning home

Comments (0)

Leave a Comment